428 related articles for article (PubMed ID: 36077103)
1. The Role of Transcription Factor PPAR-γ in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells.
Sobolev VV; Tchepourina E; Korsunskaya IM; Geppe NA; Chebysheva SN; Soboleva AG; Mezentsev A
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077103
[TBL] [Abstract][Full Text] [Related]
2. Variations in the genes encoding the peroxisome proliferator-activated receptors alpha and gamma in psoriasis.
Mössner R; Kaiser R; Matern P; Krüger U; Westphal GA; Brockmöller J; Ziegler A; Neumann C; König IR; Reich K
Arch Dermatol Res; 2004 Jun; 296(1):1-5. PubMed ID: 15083308
[TBL] [Abstract][Full Text] [Related]
3. Biological action of docosahexaenoic acid in a 3D tissue-engineered psoriatic skin model: Focus on the PPAR signaling pathway.
Morin S; Simard M; Flamand N; Pouliot R
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Dec; 1866(12):159032. PubMed ID: 34428549
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptors in cutaneous biology.
Kuenzli S; Saurat JH
Br J Dermatol; 2003 Aug; 149(2):229-36. PubMed ID: 12932225
[TBL] [Abstract][Full Text] [Related]
5. Potential therapeutic role of peroxisome proliferator activated receptor-gamma agonists in psoriasis.
Malhotra S; Bansal D; Shafiq N; Pandhi P; Kumar B
Expert Opin Pharmacother; 2005 Aug; 6(9):1455-61. PubMed ID: 16086634
[TBL] [Abstract][Full Text] [Related]
6. Skin-targeted inhibition of PPAR β/δ by selective antagonists to treat PPAR β/δ-mediated psoriasis-like skin disease in vivo.
Hack K; Reilly L; Palmer C; Read KD; Norval S; Kime R; Booth K; Foerster J
PLoS One; 2012; 7(5):e37097. PubMed ID: 22606335
[TBL] [Abstract][Full Text] [Related]
7. PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming.
Blunder S; Pavel P; Minzaghi D; Dubrac S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298981
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptors and their relevance to dermatology.
Friedmann PS; Cooper HL; Healy E
Acta Derm Venereol; 2005; 85(3):194-202. PubMed ID: 16040401
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptors as new molecular targets in psoriasis.
Kuenzli S; Saurat JH
Curr Drug Targets Inflamm Allergy; 2004 Jun; 3(2):205-11. PubMed ID: 15180475
[TBL] [Abstract][Full Text] [Related]
10. miR-203 promotes HaCaT cell overproliferation through targeting LXR-α and PPAR-γ.
Xiao Y; Wang H; Wang C; Zeng B; Tang X; Zhang Y; Peng Y; Luo M; Huang P; Yang Z
Cell Cycle; 2020 Aug; 19(15):1928-1940. PubMed ID: 32594829
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry.
Lin X; Meng X; Song Z; Lin J
Mol Cell Biochem; 2022 Jul; 477(7):1905-1920. PubMed ID: 35348980
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
[TBL] [Abstract][Full Text] [Related]
13. Analysis of
Sobolev V; Nesterova A; Soboleva A; Mezentsev A; Dvoriankova E; Piruzyan A; Denisova E; Melnichenko O; Korsunskaya I
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445309
[TBL] [Abstract][Full Text] [Related]
14. The role of PPAR-gamma receptor in pruritus.
Ostadhadi S; Nikoui V; Haj-Mirzaian A; Kordjazy N; Dehpour AR
Eur J Pharmacol; 2015 Sep; 762():322-5. PubMed ID: 26057695
[TBL] [Abstract][Full Text] [Related]
15. Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin.
Westergaard M; Henningsen J; Johansen C; Rasmussen S; Svendsen ML; Jensen UB; Schrøder HD; Staels B; Iversen L; Bolund L; Kragballe K; Kristiansen K
J Invest Dermatol; 2003 Nov; 121(5):1104-17. PubMed ID: 14708613
[TBL] [Abstract][Full Text] [Related]
16. In vivo imaging reveals selective PPAR activity in the skin of peroxisome proliferator-activated receptor responsive element-luciferase reporter mice.
El-Jamal N; Dubuquoy L; Auwerx J; Bertin B; Desreumaux P
Exp Dermatol; 2013 Feb; 22(2):137-40. PubMed ID: 23362873
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritis.
Lima Ede A; Lima MM; Marques CD; Duarte AL; Pita Ida R; Pita MG
An Bras Dermatol; 2013; 88(6):1029-35. PubMed ID: 24474126
[TBL] [Abstract][Full Text] [Related]
18. Functions of peroxisome proliferator-activated receptors (PPAR) in skin homeostasis.
Di-Poï N; Michalik L; Desvergne B; Wahli W
Lipids; 2004 Nov; 39(11):1093-9. PubMed ID: 15726824
[TBL] [Abstract][Full Text] [Related]
19. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.
Schoonjans K; Staels B; Auwerx J
Biochim Biophys Acta; 1996 Jul; 1302(2):93-109. PubMed ID: 8695669
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease.
Michalik L; Wahli W
Biochim Biophys Acta; 2007 Aug; 1771(8):991-8. PubMed ID: 17400022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
